BA
Brian Abrahams RBC Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
SION
1
Sionna Therapeutics, Inc. Common Stock
SION
$1.08B
| $24.55 | $22 |
10%
downside
| Sector Perform | 15 hours ago |
|
2
Xenon Pharmaceuticals
XENE
$2.99B
| $38.83 | $55 |
42%
upside
| Outperform | yesterday |
|
3
PTC Therapeutics
PTCT
$4.41B
| $55.55 | $63 |
13%
upside
| Outperform | 26 days ago |
|
4
Gilead Sciences
GILD
$140B
| $112.99 | $98 |
13%
downside
| Sector Perform | 26 days ago |
|
5
89bio
ETNB
$1.37B
| $9.24 | $11 |
19%
upside
| Sector Perform | 26 days ago |
|
6
Acadia Pharmaceuticals
ACAD
$4.34B
| $25.72 | $40 |
56%
upside
| Outperform | 27 days ago |
|
7
Vertex Pharmaceuticals
VRTX
$102B
| $396.62 | $405 |
2%
upside
| Sector Perform | 29 days ago |
|
8
Prothena Corp
PRTA
$452M
| $8.39 | $10 |
19%
upside
| Sector Perform | 29 days ago |
|
9
Regeneron Pharmaceuticals
REGN
$59.8B
| $563.80 | $695 |
23%
upside
| Sector Perform | 1 month ago |
|
10
Biogen
BIIB
$20.8B
| $141.62 | $219 |
55%
upside
| Outperform | 1 month ago |
|
11
Neurocrine Biosciences
NBIX
$13.5B
| $136.11 | $144 |
6%
upside
| Outperform | 1 month ago |
|
12
Incyte
INCY
$17B
| $86.96 | $72 |
17%
downside
| Sector Perform | 1 month ago |
|
13
Sarepta Therapeutics
SRPT
$1.98B
| $18.95 | $23 |
21%
upside
| Sector Perform | 1 month ago |
|
14
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.29 | $13 |
57%
upside
| Outperform | 2 months ago |
|
15
Cidara Therapeutics
CDTX
$1.61B
| $63.43 | $75 |
18%
upside
| Outperform | 2 months ago |
|
16
MoonLake Immunotherapeutics
MLTX
$3.78B
| $59.50 | $67 |
13%
upside
| Outperform | 3 months ago |
|
|
CTNM
17
Contineum Therapeutics
CTNM
$297M
| $10.58 | $31 |
193%
upside
| Outperform | 3 months ago |
|
18
Legend Biotech
LEGN
$6.64B
| $35.95 | $84 |
134%
upside
| Outperform | 4 months ago |
|
19
GH Research
GHRS
$870M
| $14.02 | $31 |
121%
upside
| Outperform | 6 months ago |
|
20
Neumora Therapeutics
NMRA
$283M
| $1.75 | $4 |
129%
upside
| Sector Perform | 6 months ago |
|
21
Axsome Therapeutics
AXSM
$6.09B
| $122 | $143 |
17%
upside
| Outperform | 7 months ago |
|
22
NewAmsterdam Pharma
NAMS
$2.8B
| $24.88 | $40 |
61%
upside
| Outperform | 7 months ago |
|
23
Galapagos
GLPG
$2.06B
| $31.26 | $30 |
4%
downside
| Sector Perform | 10 months ago |
|
24
MindMed
MNMD
$689M
| $9.06 | $22 |
143%
upside
| Outperform | 1 year ago |
|
25
ATAI Life Sciences
ATAI
$969M
| $4.52 | $9 |
99%
upside
| Sector Perform | 3 years ago |
|